273 related articles for article (PubMed ID: 16128828)
21. Shared antigens of Porphyromonas gingivalis and Bacteroides forsythus.
Vasel D; Sims TJ; Bainbridge B; Houston L; Darveau R; Page RC
Oral Microbiol Immunol; 1996 Aug; 11(4):226-35. PubMed ID: 9002874
[TBL] [Abstract][Full Text] [Related]
22. Response of guinea pigs to a vaccine containing a new adjuvant (SAF) and gram-negative bacteria.
Houston L; Moncla BJ; Page R; Engel D
Lab Anim Sci; 1995 Feb; 45(1):59-66. PubMed ID: 7752616
[TBL] [Abstract][Full Text] [Related]
23. Serum antibody response to periodontal pathogens and herpes simplex virus in relation to classic risk factors of cardiovascular disease.
Vilkuna-Rautiainen T; Pussinen PJ; Roivainen M; Petäys T; Jousilahti P; Hovi T; Vartiainen E; Asikainen S
Int J Epidemiol; 2006 Dec; 35(6):1486-94. PubMed ID: 16997850
[TBL] [Abstract][Full Text] [Related]
24. Serum IgG1 and IgG2 antibody responses to Porphyromonas gingivalis in patients with periodontitis.
Booth V; Solakoglu O; Bavisha N; Curtis MA
Oral Microbiol Immunol; 2006 Apr; 21(2):93-9. PubMed ID: 16476018
[TBL] [Abstract][Full Text] [Related]
25. The humoral response in patients with periodontitis: effects of treatment and prospects for a vaccine.
Page RC
Compend Suppl; 1994; (18):S666-71; quiz S714-7. PubMed ID: 8039203
[TBL] [Abstract][Full Text] [Related]
26. Porphyromonas gingivalis-specific immunoglobulin G prevents P. gingivalis-elicited oral bone loss in a murine model.
Gibson FC; Gonzalez DA; Wong J; Genco CA
Infect Immun; 2004 Apr; 72(4):2408-11. PubMed ID: 15039370
[TBL] [Abstract][Full Text] [Related]
27. Intranasal immunization with Porphyromonas gingivalis and atherosclerosis.
Koizumi Y; Kurita-Ochiai T; Oguchi S; Yamamoto M
Immunopharmacol Immunotoxicol; 2009; 31(3):352-7. PubMed ID: 19555215
[TBL] [Abstract][Full Text] [Related]
28. Application of vaccine technology to prevention of Pseudomonas aeruginosa infections.
Pier G
Expert Rev Vaccines; 2005 Oct; 4(5):645-56. PubMed ID: 16221066
[TBL] [Abstract][Full Text] [Related]
29. T-cell clonality to Porphyromonas gingivalis and human heat shock protein 60s in patients with atherosclerosis and periodontitis.
Yamazaki K; Ohsawa Y; Itoh H; Ueki K; Tabeta K; Oda T; Nakajima T; Yoshie H; Saito S; Oguma F; Kodama M; Aizawa Y; Seymour GJ
Oral Microbiol Immunol; 2004 Jun; 19(3):160-7. PubMed ID: 15107067
[TBL] [Abstract][Full Text] [Related]
30. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
31. Porphyromonas gingivalis may play an important role in the pathogenesis of periodontitis-associated rheumatoid arthritis.
Liao F; Li Z; Wang Y; Shi B; Gong Z; Cheng X
Med Hypotheses; 2009 Jun; 72(6):732-5. PubMed ID: 19246161
[TBL] [Abstract][Full Text] [Related]
32. Vaccination against periodontitis: the saga continues.
Sharma DC; Prasad SB; Karthikeyan BV
Expert Rev Vaccines; 2007 Aug; 6(4):579-90. PubMed ID: 17669011
[TBL] [Abstract][Full Text] [Related]
33. Characteristics of systemic antibody responses of nonhuman primates following active immunization with Porphyromonas gingivalis, Prevotella intermedia and Bacteroides fragilis.
Giardino A; Ebersole JL; Holt SC
Oral Microbiol Immunol; 1996 Apr; 11(2):79-87. PubMed ID: 8941758
[TBL] [Abstract][Full Text] [Related]
34. Sublingual vaccination with outer membrane protein of Porphyromonas gingivalis and Flt3 ligand elicits protective immunity in the oral cavity.
Zhang T; Hashizume T; Kurita-Ochiai T; Yamamoto M
Biochem Biophys Res Commun; 2009 Dec; 390(3):937-41. PubMed ID: 19852927
[TBL] [Abstract][Full Text] [Related]
35. Subcutaneous vaccination with Porphyromonas gingivalis ameliorates periodontitis by modulating Th17/Treg imbalance in a murine model.
Wang L; Guan N; Jin Y; Lin X; Gao H
Int Immunopharmacol; 2015 Mar; 25(1):65-73. PubMed ID: 25604387
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of a monovalent companion animal periodontal disease vaccine in an experimental mouse periodontitis model.
Hardham J; Reed M; Wong J; King K; Laurinat B; Sfintescu C; Evans RT
Vaccine; 2005 May; 23(24):3148-56. PubMed ID: 15837214
[TBL] [Abstract][Full Text] [Related]
37. Immunoprotective effects of a hemin-binding peptide derived from hemagglutinin-2 against infection with Porphyromonas gingivalis.
Zhu YC; An T; Liu Y; Zhang ZL; Yang QB
Mol Oral Microbiol; 2018 Feb; 33(1):81-88. PubMed ID: 28984085
[TBL] [Abstract][Full Text] [Related]
38. Periodontal vaccine.
Malhotra R; Kapoor A; Grover V; Tuli AK
Indian J Dent Res; 2011; 22(5):698-705. PubMed ID: 22406716
[TBL] [Abstract][Full Text] [Related]
39. Passive immunization against dental caries and periodontal disease: development of recombinant and human monoclonal antibodies.
Abiko Y
Crit Rev Oral Biol Med; 2000; 11(2):140-58. PubMed ID: 12002812
[TBL] [Abstract][Full Text] [Related]
40. Induction of immune response and prevention of alveolar bone loss with recombinant Porphyromonas gingivalis peptidylarginine deiminase.
Zhu C; Yang J; Sun J; Shi J; Gou J; Li A
Arch Oral Biol; 2013 Dec; 58(12):1777-83. PubMed ID: 24200304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
